In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentration for Secnidazole That Correlates With Treatment Success Article Swipe
Keonte J. Graves
,
Jan Novák
,
Hemant K. Tiwari
,
W. Evan Secor
,
Peter Augostini
,
Christina A. Muzny
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1097/olq.0000000000001992
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1097/olq.0000000000001992
We determined the in vitro minimum lethal concentration of secnidazole and assessed the correlation with clinical susceptibility among Trichomonas vaginalis isolates obtained from 71 women, of whom 66 were successfully treated with this medication. A minimum lethal concentration ≤12.5 μg/mL correlated with clinical susceptibility in this study.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/olq.0000000000001992
- OA Status
- green
- References
- 19
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4396509265
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4396509265Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/olq.0000000000001992Digital Object Identifier
- Title
-
In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentration for Secnidazole That Correlates With Treatment SuccessWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-04-30Full publication date if available
- Authors
-
Keonte J. Graves, Jan Novák, Hemant K. Tiwari, W. Evan Secor, Peter Augostini, Christina A. MuznyList of authors in order
- Landing page
-
https://doi.org/10.1097/olq.0000000000001992Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/11522018Direct OA link when available
- Concepts
-
Trichomonas vaginalis, Medicine, In vitro, Drug, Internal medicine, Microbiology, Pharmacology, Gynecology, Biology, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
19Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4396509265 |
|---|---|
| doi | https://doi.org/10.1097/olq.0000000000001992 |
| ids.doi | https://doi.org/10.1097/olq.0000000000001992 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38687328 |
| ids.openalex | https://openalex.org/W4396509265 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | Q000187 |
| mesh[0].descriptor_ui | D014246 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | drug effects |
| mesh[0].descriptor_name | Trichomonas vaginalis |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000494 |
| mesh[2].descriptor_ui | D008795 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | pharmacology |
| mesh[2].descriptor_name | Metronidazole |
| mesh[3].qualifier_ui | Q000031 |
| mesh[3].descriptor_ui | D008795 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | analogs & derivatives |
| mesh[3].descriptor_name | Metronidazole |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | Q000188 |
| mesh[5].descriptor_ui | D014247 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | drug therapy |
| mesh[5].descriptor_name | Trichomonas Vaginitis |
| mesh[6].qualifier_ui | Q000175 |
| mesh[6].descriptor_ui | D014247 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | diagnosis |
| mesh[6].descriptor_name | Trichomonas Vaginitis |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D021261 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Parasitic Sensitivity Tests |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D016896 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Treatment Outcome |
| mesh[9].qualifier_ui | Q000494 |
| mesh[9].descriptor_ui | D000981 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pharmacology |
| mesh[9].descriptor_name | Antiprotozoal Agents |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D008826 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Microbial Sensitivity Tests |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000328 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Adult |
| mesh[12].qualifier_ui | Q000187 |
| mesh[12].descriptor_ui | D014246 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug effects |
| mesh[12].descriptor_name | Trichomonas vaginalis |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D006801 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Humans |
| mesh[14].qualifier_ui | Q000494 |
| mesh[14].descriptor_ui | D008795 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | pharmacology |
| mesh[14].descriptor_name | Metronidazole |
| mesh[15].qualifier_ui | Q000031 |
| mesh[15].descriptor_ui | D008795 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | analogs & derivatives |
| mesh[15].descriptor_name | Metronidazole |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D005260 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Female |
| mesh[17].qualifier_ui | Q000188 |
| mesh[17].descriptor_ui | D014247 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | drug therapy |
| mesh[17].descriptor_name | Trichomonas Vaginitis |
| mesh[18].qualifier_ui | Q000175 |
| mesh[18].descriptor_ui | D014247 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | diagnosis |
| mesh[18].descriptor_name | Trichomonas Vaginitis |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D021261 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Parasitic Sensitivity Tests |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D016896 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Treatment Outcome |
| mesh[21].qualifier_ui | Q000494 |
| mesh[21].descriptor_ui | D000981 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | pharmacology |
| mesh[21].descriptor_name | Antiprotozoal Agents |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008826 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Microbial Sensitivity Tests |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000328 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Adult |
| mesh[24].qualifier_ui | Q000187 |
| mesh[24].descriptor_ui | D014246 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug effects |
| mesh[24].descriptor_name | Trichomonas vaginalis |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D006801 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Humans |
| mesh[26].qualifier_ui | Q000494 |
| mesh[26].descriptor_ui | D008795 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | pharmacology |
| mesh[26].descriptor_name | Metronidazole |
| mesh[27].qualifier_ui | Q000031 |
| mesh[27].descriptor_ui | D008795 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | analogs & derivatives |
| mesh[27].descriptor_name | Metronidazole |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D005260 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Female |
| mesh[29].qualifier_ui | Q000188 |
| mesh[29].descriptor_ui | D014247 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | drug therapy |
| mesh[29].descriptor_name | Trichomonas Vaginitis |
| mesh[30].qualifier_ui | Q000175 |
| mesh[30].descriptor_ui | D014247 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | diagnosis |
| mesh[30].descriptor_name | Trichomonas Vaginitis |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D021261 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Parasitic Sensitivity Tests |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D016896 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Treatment Outcome |
| mesh[33].qualifier_ui | Q000494 |
| mesh[33].descriptor_ui | D000981 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | pharmacology |
| mesh[33].descriptor_name | Antiprotozoal Agents |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D008826 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Microbial Sensitivity Tests |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000328 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Adult |
| mesh[36].qualifier_ui | Q000187 |
| mesh[36].descriptor_ui | D014246 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | drug effects |
| mesh[36].descriptor_name | Trichomonas vaginalis |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D006801 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Humans |
| mesh[38].qualifier_ui | Q000494 |
| mesh[38].descriptor_ui | D008795 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | pharmacology |
| mesh[38].descriptor_name | Metronidazole |
| mesh[39].qualifier_ui | Q000031 |
| mesh[39].descriptor_ui | D008795 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | analogs & derivatives |
| mesh[39].descriptor_name | Metronidazole |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D005260 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Female |
| mesh[41].qualifier_ui | Q000188 |
| mesh[41].descriptor_ui | D014247 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | drug therapy |
| mesh[41].descriptor_name | Trichomonas Vaginitis |
| mesh[42].qualifier_ui | Q000175 |
| mesh[42].descriptor_ui | D014247 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | diagnosis |
| mesh[42].descriptor_name | Trichomonas Vaginitis |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D021261 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Parasitic Sensitivity Tests |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D016896 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Treatment Outcome |
| mesh[45].qualifier_ui | Q000494 |
| mesh[45].descriptor_ui | D000981 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | pharmacology |
| mesh[45].descriptor_name | Antiprotozoal Agents |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D008826 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Microbial Sensitivity Tests |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D000328 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Adult |
| mesh[48].qualifier_ui | Q000187 |
| mesh[48].descriptor_ui | D014246 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | drug effects |
| mesh[48].descriptor_name | Trichomonas vaginalis |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D006801 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Humans |
| type | article |
| title | In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentration for Secnidazole That Correlates With Treatment Success |
| biblio.issue | 11 |
| biblio.volume | 51 |
| biblio.last_page | e45 |
| biblio.first_page | e43 |
| topics[0].id | https://openalex.org/T10428 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2404 |
| topics[0].subfield.display_name | Microbiology |
| topics[0].display_name | Reproductive tract infections research |
| topics[1].id | https://openalex.org/T10600 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9973999857902527 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Reproductive Health and Contraception |
| topics[2].id | https://openalex.org/T10459 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9824000000953674 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2738 |
| topics[2].subfield.display_name | Psychiatry and Mental health |
| topics[2].display_name | Sexual function and dysfunction studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2781114625 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8756409883499146 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q132595 |
| concepts[0].display_name | Trichomonas vaginalis |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.8442829251289368 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C202751555 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6955704689025879 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[2].display_name | In vitro |
| concepts[3].id | https://openalex.org/C2780035454 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5197510123252869 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[3].display_name | Drug |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.34397566318511963 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C89423630 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3349798321723938 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[5].display_name | Microbiology |
| concepts[6].id | https://openalex.org/C98274493 |
| concepts[6].level | 1 |
| concepts[6].score | 0.258247435092926 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[6].display_name | Pharmacology |
| concepts[7].id | https://openalex.org/C29456083 |
| concepts[7].level | 1 |
| concepts[7].score | 0.22739091515541077 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[7].display_name | Gynecology |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.11746695637702942 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C54355233 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0862082839012146 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[9].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/trichomonas-vaginalis |
| keywords[0].score | 0.8756409883499146 |
| keywords[0].display_name | Trichomonas vaginalis |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.8442829251289368 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/in-vitro |
| keywords[2].score | 0.6955704689025879 |
| keywords[2].display_name | In vitro |
| keywords[3].id | https://openalex.org/keywords/drug |
| keywords[3].score | 0.5197510123252869 |
| keywords[3].display_name | Drug |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.34397566318511963 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/microbiology |
| keywords[5].score | 0.3349798321723938 |
| keywords[5].display_name | Microbiology |
| keywords[6].id | https://openalex.org/keywords/pharmacology |
| keywords[6].score | 0.258247435092926 |
| keywords[6].display_name | Pharmacology |
| keywords[7].id | https://openalex.org/keywords/gynecology |
| keywords[7].score | 0.22739091515541077 |
| keywords[7].display_name | Gynecology |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.11746695637702942 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/genetics |
| keywords[9].score | 0.0862082839012146 |
| keywords[9].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1097/olq.0000000000001992 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S170339494 |
| locations[0].source.issn | 0148-5717, 1537-4521 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0148-5717 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Sexually Transmitted Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Sexually Transmitted Diseases |
| locations[0].landing_page_url | https://doi.org/10.1097/olq.0000000000001992 |
| locations[1].id | pmid:38687328 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Sexually transmitted diseases |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38687328 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11522018 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Sex Transm Dis |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11522018 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5079276380 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8646-3801 |
| authorships[0].author.display_name | Keonte J. Graves |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I32389192 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210121222 |
| authorships[0].affiliations[1].raw_affiliation_string | Sources of Support: This study was supported by an investigator-initiated award granted to Christina Muzny, MD, MSPH by Lupin Pharmaceuticals. Lupin Pharmaceuticals had no influence on the conduct of the study, nor the results reported. Keonte J. Graves, MS is currently funded by an F31 award from NIAID (1F31AI161785 01A1). |
| authorships[0].institutions[0].id | https://openalex.org/I4210121222 |
| authorships[0].institutions[0].ror | https://ror.org/01wxsyf11 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210121222 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Lupin Pharmaceuticals (United States) |
| authorships[0].institutions[1].id | https://openalex.org/I32389192 |
| authorships[0].institutions[1].ror | https://ror.org/008s83205 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I32389192 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | University of Alabama at Birmingham |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Keonte J. Graves |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, Sources of Support: This study was supported by an investigator-initiated award granted to Christina Muzny, MD, MSPH by Lupin Pharmaceuticals. Lupin Pharmaceuticals had no influence on the conduct of the study, nor the results reported. Keonte J. Graves, MS is currently funded by an F31 award from NIAID (1F31AI161785 01A1). |
| authorships[1].author.id | https://openalex.org/A5102943957 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6288-5025 |
| authorships[1].author.display_name | Jan Novák |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I32389192 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL |
| authorships[1].institutions[0].id | https://openalex.org/I32389192 |
| authorships[1].institutions[0].ror | https://ror.org/008s83205 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I32389192 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Alabama at Birmingham |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jan Novak |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL |
| authorships[2].author.id | https://openalex.org/A5052354656 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Hemant K. Tiwari |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I32389192 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL |
| authorships[2].institutions[0].id | https://openalex.org/I32389192 |
| authorships[2].institutions[0].ror | https://ror.org/008s83205 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I32389192 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of Alabama at Birmingham |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Hemant K. Tiwari |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL |
| authorships[3].author.id | https://openalex.org/A5076715795 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0584-5961 |
| authorships[3].author.display_name | W. Evan Secor |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439, https://openalex.org/I4210164764 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA |
| authorships[3].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[3].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[3].institutions[1].id | https://openalex.org/I4210164764 |
| authorships[3].institutions[1].ror | https://ror.org/05tcdh256 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210164764 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | Division of Parasitic Diseases and Malaria |
| authorships[3].institutions[2].id | https://openalex.org/I4210121439 |
| authorships[3].institutions[2].ror | https://ror.org/02ggwpx62 |
| authorships[3].institutions[2].type | facility |
| authorships[3].institutions[2].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210109567, https://openalex.org/I4210121439 |
| authorships[3].institutions[2].country_code | US |
| authorships[3].institutions[2].display_name | National Center for Emerging and Zoonotic Infectious Diseases |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | W. Evan Secor |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA |
| authorships[4].author.id | https://openalex.org/A5032005732 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Peter Augostini |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210121439, https://openalex.org/I4210164764 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA |
| authorships[4].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[4].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[4].institutions[1].id | https://openalex.org/I4210164764 |
| authorships[4].institutions[1].ror | https://ror.org/05tcdh256 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210164764 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | Division of Parasitic Diseases and Malaria |
| authorships[4].institutions[2].id | https://openalex.org/I4210121439 |
| authorships[4].institutions[2].ror | https://ror.org/02ggwpx62 |
| authorships[4].institutions[2].type | facility |
| authorships[4].institutions[2].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210109567, https://openalex.org/I4210121439 |
| authorships[4].institutions[2].country_code | US |
| authorships[4].institutions[2].display_name | National Center for Emerging and Zoonotic Infectious Diseases |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Peter Augostini |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA |
| authorships[5].author.id | https://openalex.org/A5027096845 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4005-3858 |
| authorships[5].author.display_name | Christina A. Muzny |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210121222 |
| authorships[5].affiliations[0].raw_affiliation_string | Sources of Support: This study was supported by an investigator-initiated award granted to Christina Muzny, MD, MSPH by Lupin Pharmaceuticals. Lupin Pharmaceuticals had no influence on the conduct of the study, nor the results reported. Keonte J. Graves, MS is currently funded by an F31 award from NIAID (1F31AI161785 01A1). |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I32389192 |
| authorships[5].affiliations[1].raw_affiliation_string | Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL |
| authorships[5].institutions[0].id | https://openalex.org/I4210121222 |
| authorships[5].institutions[0].ror | https://ror.org/01wxsyf11 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210121222 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Lupin Pharmaceuticals (United States) |
| authorships[5].institutions[1].id | https://openalex.org/I32389192 |
| authorships[5].institutions[1].ror | https://ror.org/008s83205 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I32389192 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | University of Alabama at Birmingham |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Christina A. Muzny |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, Sources of Support: This study was supported by an investigator-initiated award granted to Christina Muzny, MD, MSPH by Lupin Pharmaceuticals. Lupin Pharmaceuticals had no influence on the conduct of the study, nor the results reported. Keonte J. Graves, MS is currently funded by an F31 award from NIAID (1F31AI161785 01A1). |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11522018 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentration for Secnidazole That Correlates With Treatment Success |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10428 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2404 |
| primary_topic.subfield.display_name | Microbiology |
| primary_topic.display_name | Reproductive tract infections research |
| related_works | https://openalex.org/W2355580368, https://openalex.org/W2436913278, https://openalex.org/W2418739893, https://openalex.org/W2372597127, https://openalex.org/W2293265169, https://openalex.org/W2348481553, https://openalex.org/W2412948879, https://openalex.org/W76429041, https://openalex.org/W2375320597, https://openalex.org/W2365923802 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:11522018 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Sex Transm Dis |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11522018 |
| primary_location.id | doi:10.1097/olq.0000000000001992 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S170339494 |
| primary_location.source.issn | 0148-5717, 1537-4521 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0148-5717 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Sexually Transmitted Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Sexually Transmitted Diseases |
| primary_location.landing_page_url | https://doi.org/10.1097/olq.0000000000001992 |
| publication_date | 2024-04-30 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3185444663, https://openalex.org/W2790614158, https://openalex.org/W3164421300, https://openalex.org/W4322770793, https://openalex.org/W3164325962, https://openalex.org/W1507812441, https://openalex.org/W4362470712, https://openalex.org/W2100194553, https://openalex.org/W4210968944, https://openalex.org/W6807708736, https://openalex.org/W2078495656, https://openalex.org/W2102824635, https://openalex.org/W4322487110, https://openalex.org/W4383874960, https://openalex.org/W3136410105, https://openalex.org/W1988128159, https://openalex.org/W2109981777, https://openalex.org/W2792916938, https://openalex.org/W2235512452 |
| referenced_works_count | 19 |
| abstract_inverted_index.A | 35 |
| abstract_inverted_index.66 | 28 |
| abstract_inverted_index.71 | 24 |
| abstract_inverted_index.We | 1 |
| abstract_inverted_index.in | 4, 45 |
| abstract_inverted_index.of | 9, 26 |
| abstract_inverted_index.and | 11 |
| abstract_inverted_index.the | 3, 13 |
| abstract_inverted_index.from | 23 |
| abstract_inverted_index.this | 33, 46 |
| abstract_inverted_index.were | 29 |
| abstract_inverted_index.whom | 27 |
| abstract_inverted_index.with | 15, 32, 42 |
| abstract_inverted_index.among | 18 |
| abstract_inverted_index.vitro | 5 |
| abstract_inverted_index.lethal | 7, 37 |
| abstract_inverted_index.study. | 47 |
| abstract_inverted_index.women, | 25 |
| abstract_inverted_index.μg/mL | 40 |
| abstract_inverted_index.minimum | 6, 36 |
| abstract_inverted_index.treated | 31 |
| abstract_inverted_index.≤12.5 | 39 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.assessed | 12 |
| abstract_inverted_index.clinical | 16, 43 |
| abstract_inverted_index.isolates | 21 |
| abstract_inverted_index.obtained | 22 |
| abstract_inverted_index.vaginalis | 20 |
| abstract_inverted_index.correlated | 41 |
| abstract_inverted_index.determined | 2 |
| abstract_inverted_index.Trichomonas | 19 |
| abstract_inverted_index.correlation | 14 |
| abstract_inverted_index.medication. | 34 |
| abstract_inverted_index.secnidazole | 10 |
| abstract_inverted_index.successfully | 30 |
| abstract_inverted_index.concentration | 8, 38 |
| abstract_inverted_index.susceptibility | 17, 44 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.069815 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |